Evommune EVMN Payments Of Stock Issuance Costs
Payments Of Stock Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.
The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's payments of stock issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's payments of stock issuance costs?
- Evommune (EVMN) reported payments of stock issuance costs of $1.05M in Q4 2025.
- What does payments of stock issuance costs mean?
- Reflects the direct costs incurred in the process of issuing equity, such as legal, accounting, and underwriting fees. These costs reduce the net proceeds received from capital raises and are capitalized or expensed according to accounting standards. High costs relative to proceeds may indicate inefficiencies in the company's financing activities.